I sense a cap raise or asset sale/farm out to occur. Not saying that Yemen isn’t worth chasing, whether it’s possible or likely is an issue.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%